Related Experiment Video
Updated: Apr 4, 2026

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
Venomotor changes caused by halothane acting on the sympathetic nerves.
Halothane reduces venomotor responses by affecting sympathetic nerve terminals, not smooth muscle. This anesthetic agent likely inhibits norepinephrine release, impacting venoconstriction.
Area of Science:
- Anesthesiology
- Pharmacology
- Physiology
Background:
- Halothane is an anesthetic agent known to affect cardiovascular responses.
- The precise mechanism by which halothane depresses venomotor tone is not fully understood.
- Investigating halothane's effect on sympathetic activation versus direct smooth muscle action is crucial for understanding its physiological impact.
Purpose of the Study:
- To elucidate whether halothane-induced depression of venomotor responses stems from impaired sympathetic activation or direct effects on venous smooth muscle.
- To differentiate the site of action of halothane in the context of adrenergic stimulation.
Main Methods:
- Isometric tension of isolated canine saphenous vein strips was measured.
- Adrenergic activation was induced via transmural electrical stimulation, tyramine, and norepinephrine.
- The effects of varying concentrations of halothane (0.5-3%) on basal tension and responses to adrenergic stimuli were assessed.
Main Results:
- Halothane did not significantly alter basal venous tension.
- Halothane attenuated the response to electrical stimulation but not to exogenous norepinephrine.
- Interestingly, halothane enhanced the response to tyramine, suggesting an interaction at the nerve terminal.
Conclusions:
- Halothane's inhibition of electrically induced venoconstriction in cutaneous veins is likely due to interference with norepinephrine release from nerve terminals.
- The anesthetic does not appear to directly inhibit venous smooth muscle cells.
- These findings suggest a presynaptic mechanism for halothane's effect on sympathetic neurotransmission in veins.
More Related Videos
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
05:45Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Sympathetic Activation
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Gross Anatomy of the Lungs
Hyperpnea and Hyperventilation